 Peter Kennealey
Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 11 | 2026 | 704 | 1.690 |
Why?
| | Kidney Failure, Chronic | 7 | 2025 | 598 | 1.170 |
Why?
| | Thrombelastography | 4 | 2023 | 178 | 0.840 |
Why?
| | Tissue Plasminogen Activator | 2 | 2023 | 244 | 0.730 |
Why?
| | Pancreas Transplantation | 2 | 2018 | 69 | 0.680 |
Why?
| | Organ Transplantation | 5 | 2023 | 247 | 0.670 |
Why?
| | Blood Coagulation | 2 | 2023 | 268 | 0.610 |
Why?
| | HLA Antigens | 1 | 2019 | 225 | 0.560 |
Why?
| | Carotid Arteries | 1 | 2019 | 207 | 0.550 |
Why?
| | Renal Dialysis | 3 | 2023 | 462 | 0.550 |
Why?
| | Liver Transplantation | 5 | 2024 | 823 | 0.550 |
Why?
| | Tissue and Organ Procurement | 5 | 2026 | 346 | 0.540 |
Why?
| | Simulation Training | 1 | 2018 | 134 | 0.460 |
Why?
| | General Surgery | 1 | 2018 | 207 | 0.450 |
Why?
| | Vascular Surgical Procedures | 1 | 2018 | 339 | 0.430 |
Why?
| | Tissue Donors | 4 | 2026 | 424 | 0.400 |
Why?
| | Robotic Surgical Procedures | 2 | 2026 | 182 | 0.390 |
Why?
| | Gastrectomy | 2 | 2025 | 161 | 0.390 |
Why?
| | Education, Medical, Graduate | 1 | 2018 | 557 | 0.380 |
Why?
| | Peritoneal Dialysis | 2 | 2024 | 100 | 0.370 |
Why?
| | Graft Survival | 6 | 2026 | 526 | 0.340 |
Why?
| | Obesity, Morbid | 2 | 2025 | 281 | 0.340 |
Why?
| | Brain Death | 2 | 2026 | 60 | 0.320 |
Why?
| | Clinical Competence | 1 | 2018 | 1244 | 0.300 |
Why?
| | Resuscitation | 2 | 2024 | 302 | 0.300 |
Why?
| | Hernia, Ventral | 1 | 2009 | 22 | 0.290 |
Why?
| | Catheters, Indwelling | 2 | 2024 | 96 | 0.250 |
Why?
| | Health Services Accessibility | 2 | 2025 | 1098 | 0.240 |
Why?
| | Living Donors | 3 | 2021 | 280 | 0.240 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 2025 | 7 | 0.230 |
Why?
| | Laparoscopy | 3 | 2024 | 475 | 0.210 |
Why?
| | Middle Aged | 14 | 2026 | 35875 | 0.200 |
Why?
| | Informed Consent | 1 | 2024 | 198 | 0.180 |
Why?
| | Female | 20 | 2026 | 78271 | 0.180 |
Why?
| | Male | 18 | 2026 | 72315 | 0.180 |
Why?
| | Directed Tissue Donation | 1 | 2021 | 5 | 0.180 |
Why?
| | Humans | 31 | 2026 | 144759 | 0.170 |
Why?
| | Cardiovascular System | 1 | 2023 | 137 | 0.170 |
Why?
| | Reperfusion | 1 | 2020 | 54 | 0.160 |
Why?
| | Adult | 12 | 2026 | 40449 | 0.160 |
Why?
| | Kidney Function Tests | 1 | 2020 | 157 | 0.160 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 51 | 0.160 |
Why?
| | Feasibility Studies | 1 | 2024 | 1095 | 0.150 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 103 | 0.150 |
Why?
| | Postoperative Period | 1 | 2020 | 354 | 0.150 |
Why?
| | Treatment Outcome | 8 | 2026 | 11679 | 0.140 |
Why?
| | Retrospective Studies | 9 | 2026 | 17066 | 0.140 |
Why?
| | Blood Coagulation Disorders | 1 | 2020 | 189 | 0.140 |
Why?
| | Predictive Value of Tests | 2 | 2020 | 2115 | 0.140 |
Why?
| | Prospective Studies | 4 | 2020 | 7990 | 0.140 |
Why?
| | Registries | 2 | 2024 | 2385 | 0.130 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 157 | 0.130 |
Why?
| | Transplantation, Homologous | 1 | 2018 | 415 | 0.130 |
Why?
| | Cattle | 1 | 2019 | 1000 | 0.130 |
Why?
| | Family | 1 | 2021 | 679 | 0.120 |
Why?
| | Death | 2 | 2023 | 130 | 0.120 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2011 | 630 | 0.110 |
Why?
| | Aged | 7 | 2026 | 25913 | 0.110 |
Why?
| | Diabetes Complications | 1 | 2016 | 222 | 0.110 |
Why?
| | Markov Chains | 2 | 2025 | 129 | 0.110 |
Why?
| | Diabetic Nephropathies | 1 | 2018 | 318 | 0.110 |
Why?
| | Obesity | 2 | 2025 | 3077 | 0.110 |
Why?
| | Catheterization | 2 | 2024 | 183 | 0.100 |
Why?
| | Postoperative Complications | 3 | 2024 | 2919 | 0.100 |
Why?
| | Polytetrafluoroethylene | 1 | 2011 | 25 | 0.090 |
Why?
| | Vascular Patency | 1 | 2011 | 121 | 0.080 |
Why?
| | Decision Support Techniques | 2 | 2025 | 456 | 0.080 |
Why?
| | Protons | 1 | 2011 | 95 | 0.080 |
Why?
| | Fibrinolysis | 2 | 2023 | 162 | 0.080 |
Why?
| | Blood Vessel Prosthesis | 1 | 2011 | 140 | 0.080 |
Why?
| | Flavonoids | 2 | 2011 | 87 | 0.080 |
Why?
| | Waiting Lists | 2 | 2021 | 263 | 0.080 |
Why?
| | Prognosis | 1 | 2018 | 4282 | 0.080 |
Why?
| | Weight Loss | 2 | 2025 | 836 | 0.070 |
Why?
| | Piperidines | 2 | 2011 | 217 | 0.070 |
Why?
| | Surgical Mesh | 1 | 2009 | 50 | 0.070 |
Why?
| | United States | 5 | 2024 | 15966 | 0.070 |
Why?
| | Nephrectomy | 1 | 2009 | 158 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2011 | 928 | 0.070 |
Why?
| | Internship and Residency | 1 | 2018 | 1257 | 0.060 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8265 | 0.060 |
Why?
| | Biocompatible Materials | 1 | 2011 | 435 | 0.060 |
Why?
| | Body Mass Index | 2 | 2026 | 2438 | 0.060 |
Why?
| | Apoptosis | 3 | 2011 | 2430 | 0.060 |
Why?
| | Delayed Graft Function | 1 | 2026 | 46 | 0.060 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2006 | 40 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2006 | 72 | 0.060 |
Why?
| | Creatinine | 2 | 2023 | 506 | 0.060 |
Why?
| | Operative Time | 1 | 2026 | 175 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 6048 | 0.060 |
Why?
| | Abdomen | 1 | 2024 | 141 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2011 | 845 | 0.050 |
Why?
| | Young Adult | 1 | 2019 | 14105 | 0.050 |
Why?
| | Canada | 1 | 2024 | 428 | 0.050 |
Why?
| | Abdominal Pain | 1 | 2024 | 146 | 0.050 |
Why?
| | Platelet Count | 1 | 2022 | 96 | 0.050 |
Why?
| | Organ Preservation | 1 | 2023 | 130 | 0.040 |
Why?
| | Platelet Transfusion | 1 | 2022 | 80 | 0.040 |
Why?
| | Patients | 1 | 2023 | 180 | 0.040 |
Why?
| | Altruism | 1 | 2021 | 28 | 0.040 |
Why?
| | Perfusion | 1 | 2023 | 250 | 0.040 |
Why?
| | Bariatric Surgery | 1 | 2025 | 242 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2018 | 3890 | 0.040 |
Why?
| | Kidney | 1 | 2009 | 1495 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2020 | 69 | 0.040 |
Why?
| | Computer Systems | 1 | 2020 | 56 | 0.040 |
Why?
| | Viscosity | 1 | 2020 | 90 | 0.040 |
Why?
| | Liver Function Tests | 1 | 2020 | 106 | 0.040 |
Why?
| | Adolescent | 1 | 2019 | 22428 | 0.040 |
Why?
| | Length of Stay | 1 | 2026 | 1337 | 0.040 |
Why?
| | Antineoplastic Agents | 2 | 2011 | 2194 | 0.040 |
Why?
| | Patient Selection | 2 | 2016 | 719 | 0.040 |
Why?
| | Animals | 2 | 2019 | 38058 | 0.040 |
Why?
| | Blood Platelets | 1 | 2022 | 400 | 0.040 |
Why?
| | Survival Rate | 2 | 2016 | 2089 | 0.030 |
Why?
| | Aging | 1 | 2008 | 1966 | 0.030 |
Why?
| | Critical Care | 1 | 2023 | 695 | 0.030 |
Why?
| | Teratocarcinoma | 1 | 1995 | 2 | 0.030 |
Why?
| | Time Factors | 2 | 2020 | 7173 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1694 | 0.020 |
Why?
| | Cell Cycle | 2 | 2011 | 596 | 0.020 |
Why?
| | Choline Kinase | 1 | 2011 | 3 | 0.020 |
Why?
| | Choline-Phosphate Cytidylyltransferase | 1 | 2011 | 3 | 0.020 |
Why?
| | Phosphorus Isotopes | 1 | 2011 | 8 | 0.020 |
Why?
| | HCT116 Cells | 1 | 2011 | 78 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 5960 | 0.020 |
Why?
| | Camptothecin | 1 | 2011 | 140 | 0.020 |
Why?
| | Neoplasms | 1 | 2004 | 2875 | 0.020 |
Why?
| | Angiography | 1 | 2009 | 208 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2011 | 579 | 0.020 |
Why?
| | Imatinib Mesylate | 1 | 2006 | 77 | 0.010 |
Why?
| | Brain Injuries | 1 | 2010 | 507 | 0.010 |
Why?
| | Graft Rejection | 1 | 2008 | 540 | 0.010 |
Why?
| | Benzamides | 1 | 2006 | 224 | 0.010 |
Why?
| | Body Water | 1 | 2004 | 23 | 0.010 |
Why?
| | Hydrogen | 1 | 2004 | 73 | 0.010 |
Why?
| | Down-Regulation | 1 | 2006 | 627 | 0.010 |
Why?
| | Piperazines | 1 | 2006 | 381 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2004 | 919 | 0.010 |
Why?
| | RNA Polymerase II | 1 | 2006 | 351 | 0.010 |
Why?
| | Pyrimidines | 1 | 2006 | 532 | 0.010 |
Why?
| | Phosphorylation | 1 | 2006 | 1732 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2006 | 1257 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 1953 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2006 | 1496 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2008 | 5408 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2006 | 3540 | 0.010 |
Why?
| | Genes, p53 | 1 | 1995 | 67 | 0.010 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 1995 | 140 | 0.010 |
Why?
| | Mice | 1 | 2011 | 18339 | 0.010 |
Why?
| | Cell Survival | 1 | 1995 | 1098 | 0.010 |
Why?
|
|
Kennealey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|